Trial Outcomes & Findings for Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis (NCT NCT00125242)
NCT ID: NCT00125242
Last Updated: 2014-12-24
Results Overview
Accuracy of naming of pictured treated and untreated items was assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to follow-up (6 weeks following treatment). All naming responses were scored using a 0-10 scale reflecting promptness and presence of errors; scores of 8-10 received an "accuate" score and scores of 0-7 received an "inaccurate" score. A percentage accuracy score was calculated for each experimental set of items for every probe session. Baseline probe scores were compared to end of treatment and follow-up probe scores to obtain individual effect sizes for each experimental list of items for each participant (i.e., several effect sizes were calculated for each participant). All effect sizes were utlized to obtain an average effect size for each participant; these averages were then utlized to obtain a group average.
COMPLETED
NA
110 participants
End of treatment and at 6 weeks post treatment
2014-12-24
Participant Flow
Participant milestones
| Measure |
Non Treatment Stimuli Development Participants
Non-brain-injured participants who were enrolled for the purpose of stimuli development
|
SFA Treatment Participants
Stroke survivors who received experimental therapy
|
|---|---|---|
|
Overall Study
STARTED
|
94
|
16
|
|
Overall Study
COMPLETED
|
87
|
14
|
|
Overall Study
NOT COMPLETED
|
7
|
2
|
Reasons for withdrawal
| Measure |
Non Treatment Stimuli Development Participants
Non-brain-injured participants who were enrolled for the purpose of stimuli development
|
SFA Treatment Participants
Stroke survivors who received experimental therapy
|
|---|---|---|
|
Overall Study
did not qualify
|
7
|
2
|
Baseline Characteristics
Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis
Baseline characteristics by cohort
| Measure |
SFA Treatment Participants
n=16 Participants
Semantic Feature Analysis (SFA) is a word-retrieval treatment for aphasia. SFA entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, personal associations, associated actions). For some participants, treatment items were grouped by typicality of category membership (e.g, robin-typical bird and penguin-atypical bird). Training of atypical items may stimulate a broader semantic activation of the category and thus, may promote greater generalization. Treatment was applied sequentially to sets of items in single-subject, multiple baseline designs. Thus, replication of treatment effects could be evaluated within and across participants. Treatment was administered by SLPs three times per week until prescribed accuracy levels were met during probes or a maximum number of treatment sessions was completed.
|
Non Treatment Stimuli Development Participants
n=94 Participants
Participants for stimuli development provided normative data for stimuli development. e.g., Treatment items were grouped according to typicality of category membership (apple - typical fruit; coconut - atypical fruit). These participants provided the reponses that served as the basis for classifying/organizing stimuli. Because data from this group were used only for the purposes of stimuli development, no findings are reported for this group. See Cameron, R.M., Wambaugh, J.L., \& Mauszycki, S. (2008). Effects of age, gender and education on semantic fluency for living and artifact categories. Aphasiology, 22(7/8), 790-801, doi: 10.1080/02687030701818018 for related findings.
|
Total
n=110 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
21-80 Years
|
16 participants
n=5 Participants
|
94 participants
n=7 Participants
|
110 participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=5 Participants
|
47 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=5 Participants
|
47 Participants
n=7 Participants
|
59 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: End of treatment and at 6 weeks post treatmentPopulation: SFA Treatment Participants were stroke-survivors with chronic aphasia who had significant word retrieval difficulties. Non Treatment Stimuli Development Participants were only enrolled in the study to provide data for the development of treatment stimuli. As such, they were not assessed for the outcome measure.
Accuracy of naming of pictured treated and untreated items was assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to follow-up (6 weeks following treatment). All naming responses were scored using a 0-10 scale reflecting promptness and presence of errors; scores of 8-10 received an "accuate" score and scores of 0-7 received an "inaccurate" score. A percentage accuracy score was calculated for each experimental set of items for every probe session. Baseline probe scores were compared to end of treatment and follow-up probe scores to obtain individual effect sizes for each experimental list of items for each participant (i.e., several effect sizes were calculated for each participant). All effect sizes were utlized to obtain an average effect size for each participant; these averages were then utlized to obtain a group average.
Outcome measures
| Measure |
SFA Treatment Participants
n=68 participant effect sizes
Stroke survivors received Semantic Feature Analysis for the treatment of word-retrieval deficits. Each SFA treatment participant received word-retrieval therapy applied sequentially to experimental lists of items. Effect sizes were calculated for each participant for each list. An average effect size was calculated for each participant and an overall average was determined for all participants as a group.
|
|---|---|
|
Word Retrieval Accuracy
|
7.15 d-index (effect size)
Standard Deviation 3.1
|
Adverse Events
SFA Treatment Participants
NonTreatment Stimuli Development Participants
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Julie Wambaugh
VA Salt Lake City Health Care System
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place